Olav Dalgård

EASL Recommendations on Treatment of Hepatitis C 2018

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

EASL recommendations on treatment of hepatitis C: Final update of the series☆

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2020 · 1.2K citations

Pharmacy, Internal Medicine, Pharmacotherapy +15

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

Gregory J. Dore, Frederick L. Altice, Alain H. Litwin et al. · Annals of Internal Medicine · 2016 · 363 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Treatment With Pegylated Interferon and Ribavarin in Hcv Infection With Genotype 2 Or 3 for 14 Weeks: A Pilot Study

Olav Dalgård, Kristian Bjøro, Kjell B. Hellum et al. · Hepatology · 2004 · 324 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely, Olav Dalgård, Brian Conway et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 292 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14